Currency in USD
Earnings estimate | Current qtr. (Mar 2024) | Next qtr. (Jun 2024) | Current year (2024) | Next year (2025) |
---|
No. of analysts | 7 | 7 | 7 | 7 |
Avg. Estimate | -0.41 | -0.38 | -1.49 | -1.3 |
Low estimate | -0.57 | -0.52 | -2.04 | -1.96 |
High estimate | -0.27 | -0.24 | -1.06 | -0.52 |
Year ago EPS | -0.53 | -0.47 | -1.96 | -1.49 |
Revenue estimate | Current qtr. (Mar 2024) | Next qtr. (Jun 2024) | Current year (2024) | Next year (2025) |
---|
No. of analysts | 5 | 5 | 5 | 5 |
Avg. Estimate | 1.92M | 1.82M | 7.84M | 6.66M |
Low estimate | N/A | N/A | N/A | N/A |
High estimate | 3M | 3M | 13M | 12.32M |
Year ago sales | 7.92M | 880k | 5.9M | 7.84M |
Sales growth (year/est) | -75.80% | 106.80% | 32.80% | -15.10% |
Earnings history | 30/03/2023 | 29/06/2023 | 29/09/2023 | 30/12/2023 |
---|
Est. EPS | -0.46 | -0.5 | -0.5 | -0.45 |
Actual EPS | -0.53 | -0.47 | -0.43 | -0.53 |
Difference | -0.07 | 0.03 | 0.07 | -0.08 |
Surprise % | -15.20% | 6.00% | 14.00% | -17.80% |
EPS trend | Current qtr. (Mar 2024) | Next qtr. (Jun 2024) | Current year (2024) | Next year (2025) |
---|
Current estimate | -0.41 | -0.38 | -1.49 | -1.3 |
7 days ago | -0.41 | -0.38 | -1.49 | -1.3 |
30 days ago | -0.43 | -0.39 | -1.54 | -1.32 |
60 days ago | -0.43 | -0.43 | -1.68 | -1.35 |
90 days ago | -0.43 | -0.43 | -1.68 | -1.35 |
EPS revisions | Current qtr. (Mar 2024) | Next qtr. (Jun 2024) | Current year (2024) | Next year (2025) |
---|
Up last 7 days | N/A | N/A | N/A | N/A |
Up last 30 days | N/A | N/A | 1 | 1 |
Down last 7 days | N/A | N/A | N/A | N/A |
Down last 30 days | N/A | N/A | N/A | N/A |
Growth estimates | GBIO | Industry | Sector(s) | S&P 500 |
---|
Current qtr. | 22.60% | N/A | N/A | N/A |
Next qtr. | 19.10% | N/A | N/A | N/A |
Current year | 24.00% | N/A | N/A | N/A |
Next year | 12.80% | N/A | N/A | N/A |
Next 5 years (per annum) | N/A | N/A | N/A | N/A |
Past 5 years (per annum) | N/A | N/A | N/A | N/A |